Intellia Therapeutics Inc (NTLA)
Cash & Equivalents
$106.13M
Quarterly · Period ending: · USD
NTLA Cash & Equivalents
Latest reported$106.13Mperiod ending
Latest reported$106.13Mperiod ending
NTLA Quarterly Cash & Equivalents ($9.85M → $106.13M)
Quarterly Cash & Equivalents
High-resolution chart · PNG
NTLA cash & equivalents history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cash & Equivalents (USD) |
|---|---|
| 106,128,000 | |
| 134,697,000 | |
| 155,464,000 | |
| 193,389,000 | |
| 156,172,000 | |
| 126,880,000 | |
| 189,182,000 | |
| 120,495,000 | |
| 130,849,000 | |
| 171,979,000 | |
| 226,748,000 | |
| 168,027,000 | |
| 171,806,000 | |
| 294,150,000 | |
| 523,506,000 | |
| 141,194,000 | |
| 147,781,000 | |
| 133,382,000 | |
| 123,406,000 | |
| 334,736,000 | |
| 129,879,000 | |
| 141,538,000 | |
| 160,020,000 | |
| 179,746,000 | |
| 361,687,000 | |
| 80,993,000 | |
| 57,226,000 | |
| 38,440,000 | |
| 49,140,000 | |
| 47,097,000 | |
| 58,856,000 | |
| 293,248,000 | |
| 305,538,000 | |
| 327,778,000 | |
| 340,678,000 | |
| 222,264,000 | |
| 241,047,000 | |
| 257,551,000 | |
| 273,064,000 | |
| 290,618,000 | |
| 300,687,000 | |
| 64,192,000 | |
| 75,816,000 | |
| 82,612,000 | |
| 19,765,000 | |
| -9,845,000 | |
| 9,845,000 |